Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Loss-of-function mutations in filaggrin gene and malignant melanoma: a case-control study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical phenotypes of hidradenitis suppurativa

    Research output: Contribution to journalLetterResearchpeer-review

  3. Atopic dermatitis and cancer in solid organs: a systematic review and meta-analysis

    Research output: Contribution to journalComment/debateResearch

  4. Patient expectations and determinants of patient satisfaction in a dermatology outpatient clinic

    Research output: Contribution to journalLetterResearchpeer-review

  1. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exposure analysis using X-ray fluorescence device and a cobalt spot test in four patients with cobalt allergy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation.

OBJECTIVE: We aimed to investigate the association between FLG mutation status and the occurrence of malignant melanoma (MM) in Danish adults.

METHODS: The prevalence of FLG mutations in a sample of MM biopsies was compared with a FLG-genotyped cohort from two general population studies. Pearson's chi-squared and Fisher's exact tests were used to compare the two groups.

RESULTS: A total of 867 MM biopsies and 9965 general population controls were genotyped, respectively. In the MM sample, two (0.23%) individuals were homozygous and 80 (9.4%) were heterozygous mutation carriers. In the general population controls, the prevalence of FLG mutations was 18 (0.18%) and 835 (8.4%) for homozygous and heterozygous mutations, respectively. Fisher's exact test and Pearson's chi-squared test yielded non-significant P-values when the groups were compared.

CONCLUSION: FLG mutation was not associated with MM in the studied populations. This finding indicates that epidermal deficiency of filaggrin and its degradation products does not influence the risk of MM significantly.

Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology : JEADV
Volume32
Issue number2
Pages (from-to)242-244
ISSN0926-9959
DOIs
Publication statusPublished - 2018

    Research areas

  • Journal Article

ID: 51731603